# TC-6987 for the Treatment of Mild to Moderate Asthma

> **NCT01296087** · PHASE2 · COMPLETED · sponsor: **Targacept Inc.** · enrollment: 203 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** TC-6987
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01296087
- **Lead sponsor:** Targacept Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2013-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01296087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01296087, "TC-6987 for the Treatment of Mild to Moderate Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01296087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*